Evidence map›Paper›PMID 36753494›Full record

ArticlePloS one2023

Effects of gene-lifestyle interactions on obesity based on a multi-locus risk score: A cross-sectional analysis.

Sho Nakamura, Xuemin Fang, Yoshinobu Saito, Hiroto Narimatsu, Azusa Ota, Hiroaki Ikezaki, Chisato Shimanoe, Keitaro Tanaka, Yoko Kubo, Mineko Tsukamoto and 22 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Polygenic Risk and Nutrient Intake Interactions on Obesity Outcomes: A Systematic Review and Meta-Analysis of Observational Studies.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Pooled it
  2. Article
  3. The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 15 institutions in 1 country.

Sho NakamuraGraduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Kanagawa, Japan.ORCID 0000-0002-5378-9477
Xuemin FangGraduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Kanagawa, Japan.
Yoshinobu SaitoCancer Prevention and Control Division, Kanagawa Cancer Center Research Institute, Yokohama, Kanagawa, Japan.
Hiroto NarimatsuGraduate School of Health Innovation, Kanagawa University of Human Services, Kawasaki, Kanagawa, Japan.
Azusa OtaDepartment of General Internal Medicine, Kyushu University Hospital, Fukuoka, Fukuoka, Japan.
Hiroaki IkezakiDepartment of General Internal Medicine, Kyushu University Hospital, Fukuoka, Fukuoka, Japan.
Chisato ShimanoeDepartment of Pharmacy, Saga University Hospital, Nabeshima, Saga, Japan.ORCID 0000-0002-3561-9538
Keitaro TanakaDepartment of Preventive Medicine, Faculty of Medicine, Saga University, Nabeshima, Saga, Japan.
Yoko KuboDepartment of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Mineko TsukamotoDepartment of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Takashi TamuraDepartment of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Asahi HishidaDepartment of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Isao OzeDivision of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.ORCID 0000-0002-0762-1147
Yuriko N KoyanagiDivision of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan.
Yohko NakamuraCancer Prevention Center, Chiba Cancer Center Research Institute, Chiba, Chiba, Japan.
Miho KusakabeCancer Prevention Center, Chiba Cancer Center Research Institute, Chiba, Chiba, Japan.
Toshiro TakezakiDepartment of International Island and Community Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Sakuragaoka, Kagoshima, Japan.
Daisaku NishimotoSchool of Health Sciences, Faculty of Medicine, Kagoshima University, Kagoshima, Kagoshima, Japan.
Sadao SuzukiDepartment of Public Health, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Takahiro OtaniDepartment of Public Health, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi, Japan.
Nagato KuriyamaDepartment of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medicine, Nagoya, Aichi, Japan.
Daisuke MatsuiDepartment of Epidemiology for Community Health and Medicine, Kyoto Prefectural University of Medicine, Nagoya, Aichi, Japan.
Kiyonori KurikiLaboratory of Public Health, Division of Nutritional Sciences, School of Food and Nutritional Sciences, University of Shizuoka, Shizuoka, Shizuoka, Japan.
Aya KadotaNCD Epidemiology Research Center, Shiga University of Medical Science, Otsu, Shiga, Japan.
Yasuyuki NakamuraNCD Epidemiology Research Center, Shiga University of Medical Science, Otsu, Shiga, Japan.
Kokichi ArisawaDepartment of Preventive Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Tokushima, Japan.
Sakurako Katsuura-KamanoDepartment of Preventive Medicine, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Tokushima, Japan.
Masahiro NakatochiPublic Health Informatics Unit, Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Yukihide MomozawaLaboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
Michiaki KuboLaboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Yokohama, Kanagawa, Japan.
Kenji TakeuchiDepartment of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Kenji WakaiDepartment of Preventive Medicine, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
Nagoya University · JPKanagawa Prefectural Hospital Organization · JPShiga University of Medical Science · JPAichi Cancer Center · JPKagoshima University · JPKyoto Prefectural University of Medicine · JPKyushu University Hospital · JPNagoya City University · JPRIKEN Center for Integrative Medical Sciences · JPSaga University · JPTokushima University · JPChiba Cancer Center · JPKanagawa University of Human Services · JPTohoku University · JPUniversity of Shizuoka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe relationship between lifestyle and obesity is a major focus of research. Personalized nutrition, which utilizes evidence from nutrigenomics, such as gene-environment interactions, has been attracting attention in recent years. However, evidence for gene-environment interactions that can inform treatment strategies is lacking, despite some reported interactions involving dietary intake or physical activity. Utilizing gene-lifestyle interactions in practice could aid in optimizing interventions according to genetic risk.

methodsThis study aimed to elucidate the effects of gene-lifestyle interactions on body mass index (BMI). Cross-sectional data from the Japan Multi-Institutional Collaborative Cohort Study were used. Interactions between a multi-locus genetic risk score (GRS), calculated from 76 ancestry-specific single nucleotide polymorphisms, and nutritional intake or physical activity were assessed using a linear mixed-effect model.

resultsThe mean (standard deviation) BMI and GRS for all participants (n = 12,918) were 22.9 (3.0) kg/m2 and -0.07 (0.16), respectively. The correlation between GRS and BMI was r(12,916) = 0.13 (95% confidence interval [CI] 0.11-0.15, P < 0.001). An interaction between GRS and saturated fatty acid intake was observed (β = -0.11, 95% CI -0.21 to -0.02). An interaction between GRS and n-3 polyunsaturated fatty acids was also observed in the females with normal-weight subgroup (β = -0.12, 95% CI -0.22 to -0.03).

conclusionOur results provide evidence of an interaction effect between GRS and nutritional intake and physical activity. This gene-lifestyle interaction provides a basis for developing prevention or treatment interventions for obesity according to individual genetic predisposition.

Indexed as

Genetic Predisposition to DiseaseObesityBody Mass IndexCohort StudiesCross-Sectional StudiesFemaleHumansLife StylePolymorphism, Single NucleotideRisk Factors

Identifiers

PMID36753494
PMCPMC9907830
OpenAlexW4319460607

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.